Evaluation of Mac-2 binding protein glycosylation isomer (M2BPGi) as a diagnostic marker for staging liver fibrosis: a meta-analysis
PeerJ · 2024
DOI: 10.7717/peerj.17611 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PeerJ, 2024. Verfasst von Siyao Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture and Massage, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biomarkers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, National Natural Science Foundation of Sichuan Province, Central Guidance for Local Projects.
Abstract (Originalsprache)
Objective
This study aimed to assess the accuracy of Mac-2 binding protein glycosylation isomer (M2BPGi) in predicting the stage of liver fibrosis.
Methods
Articles published until October 10, 2023, were searched in the PubMed, Embase, Web of Science, and Cochrane Library databases. Pooled sensitivity, specificity, diagnostic odds ratio (DOR), summary receiver–operator curves (SROC), and Spearman’s rank correlation coefficient were used to examine the accuracy of M2BPGi in predicting the stage of liver fibrosis. A 95% confidence interval (CI) was provided for each estimate.
Results
Twenty-four studies were included in this meta-analysis, including 3,839 patients with liver fibrosis, 409 of whom progressed to stage 4 or above. The pooled sensitivity, specificity, and area under the ROC (AUC) for M2BPGi predicting liver fibrosis ≥F3 were 0.74 (95% CI [0.65–0.82]), 0.84 (95% CI [0.76–0.89]), and 14.99 (95% CI [9.28–24.21]), respectively. The pooled sensitivity, specificity, and AUC for ≥F4 were 0.80 (95% CI [0.70–0.88]), 0.80 (95% CI [0.73–0.86]), and 16.43 (95% CI [0.84–0.90]), respectively.
Conclusion
Among different sample partitions, M2BPGi has the best diagnostic performance for liver fibrosis stage ≥4. Furthermore, the cutoff of 1–2 is more accurate than that of 0–1 or 2–3 for fibrosis ≥ F3 and ≥ F4. Registration CRD42023483260.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Acupuncture and Massage, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
ORCID-Profile: Xin Yu
Förderung
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- National Natural Science Foundation of Sichuan Province
- Central Guidance for Local Projects
- National Natural Science Foundation of China
Zitieren
APA
Gong, S., Yu, X., Li, Q., Chen, M., Yu, S., & Yang, S. (2024). Evaluation of Mac-2 binding protein glycosylation isomer (M2BPGi) as a diagnostic marker for staging liver fibrosis: a meta-analysis. PeerJ. https://doi.org/10.7717/peerj.17611
Vancouver
Gong S, Yu X, Li Q, Chen M, Yu S, Yang S. Evaluation of Mac-2 binding protein glycosylation isomer (M2BPGi) as a diagnostic marker for staging liver fibrosis: a meta-analysis. PeerJ. 2024. doi:10.7717/peerj.17611
BibTeX
@article{Gong2024,
author = {Gong, Siyao and Yu, Xin and Li, Qian and Chen, Ming and Yu, Shuguang and Yang, Sha},
title = {Evaluation of Mac-2 binding protein glycosylation isomer (M2BPGi) as a diagnostic marker for staging liver fibrosis: a meta-analysis},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.17611}
}
EUVIMED